Crown Bioscience

Crown BioscienceCrown Bioscience
Crown Bioscience

Crown Bioscience

A global contract research organization specializing in preclinical and translational oncology research.

DR 592006ActiveSan Diego, United States
Rate

About

Crown Bioscience is a global contract research organization (CRO) that provides preclinical and translational research services to accelerate drug discovery and development in oncology and immuno-oncology. They offer a comprehensive suite of solutions including in vivo, in vitro, ex vivo, and in silico methods, advanced models, and biobanking services to biotech and pharmaceutical companies.
Frequently asked

What does Crown Bioscience do?

Crown Bioscience is a global contract research organization (CRO) that provides preclinical and translational research services to accelerate drug discovery and development in oncology and immuno-oncology. They offer a comprehensive suite of solutions including in vivo, in vitro, ex vivo, and in silico methods, advanced models, and biobanking services to biotech and pharmaceutical companies.

What is Crown Bioscience's revenue?

StartupHub estimates Crown Bioscience's annual revenue at $16.8M (range $14.1M to $40.8M, 42% confidence), based on comparable companies in the sector.

What is Crown Bioscience's valuation?

StartupHub estimates Crown Bioscience's effective valuation at $960.0M (range $960.0M to $11.6B, 53% confidence), based on comparable companies in the sector.

How much funding has Crown Bioscience raised?

Crown Bioscience has raised a total of $262M in funding. The most recent round on record is Acquisition.

Where is Crown Bioscience headquartered?

Crown Bioscience is headquartered in San Diego, United States.

When was Crown Bioscience founded?

Crown Bioscience was founded in 2006.

What industry does Crown Bioscience operate in?

Crown Bioscience operates in Drug Discovery, Biotech, Oncology, Contract Research Organization, Translational Research, Preclinical Research.

Comments

No comments yet. Be the first to share your take.